Big Gain For Poseida Therapeutics Inc.
Wed, Aug 03, 2022 at 07:20 PM
Poseida Therapeutics Inc. (PSTX:NASDAQ) rocketted at $4.51, representing a gain of 85.6%. On Wed, Aug 03, 2022, PSTX:NASDAQ hit a New 2-Week High of $4.51. The stock appeared on our News Catalysts scanner on Wed, Aug 03, 2022 at 06:28 PM in the 'PUBLIC OFFERING' category. From Wed, Jul 20, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
About Poseida Therapeutics Inc. (PSTX:NASDAQ)
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet...
Top 10 Gainers:
- Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ), 360.47%
- ECMOHO Limited (MOHO:NASDAQ), 146.08%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 140.31%
- Enveric Biosciences Inc. (ENVB:NASDAQ), 105.97%
- Acri Capital Acquisition Corp Cl A (ACAC:NASDAQ), 100%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 89.6%
- Poseida Therapeutics Inc. (PSTX:NASDAQ), 85.6%
- Eargo Inc. (EAR:NASDAQ), 75.64%
- Winc Inc. (WBEV:NYSEMKT), 71.43%
- Ping Identity Holding Corp. (PING:NYSE), 60.73%